Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac by Junco, Jesús A, Rodríguez, Ranfis, Fuentes, Franklin, Baladrón, Idania, Castro, Maria D, Calzada, Lesvia, Valenzuela, Carmen, Bover, Eddy, Pimentel, Eulogio, Basulto, Roberto, Arteaga, Niurka, Cid-Arregui, Angel, Sariol, Francisco, González, Lourdes, Porres-Fong, Liliana, Medina, María, Rodríguez, Ayni, Garay, A Hilda, Reyes, Osvaldo, López, Matilde, de Quesada, Lourdes, Alvarez, Allelin, Martínez, Carolina, Marrero, Marleny, Molero, Guillermo, Guerra, Alfredo, Rosales, Pedro, Capote, Carlos, Acosta, Sahily, Vela, Idania, Arzuaga, Lina, Campal, Ana, Ruiz, Erlán, Rubio, Elier, Cedeño, Pável, Sánchez, María Carmen, Cardoso, Pedro, Morán, Rolando, Fernández, Yairis, Campos, Magalys, Touduri, Henio, Bacardi, Dania, Feria, Indalecio, Ramirez, Amilcar, Cosme, Karelia, Saura, Pedro López, Quintana, Maricel, Muzio, Verena, Bringas, Ricardo, Ayala, Marta, Mendoza, Mario, Fernández, Luis E, Carr, Adriana, Herrera, Luis, Guillén, Gerardo

Get full text